These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6240405)

  • 1. Safety, tolerability and efficacy of PN 200-110, a new calcium antagonist in patients with angina and coronary heart disease.
    Handler CE; Sowton E
    Eur J Clin Pharmacol; 1984; 27(4):415-7. PubMed ID: 6240405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a new calcium antagonist PN 200-110 (isradipine) in angina pectoris.
    Taylor SH; Jackson NC; Allen J; Pool PE
    Am J Cardiol; 1987 Jan; 59(3):123B-129B. PubMed ID: 2949583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
    Mauser M; Voelker W; Karsch KR
    Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.
    Portegies MC; Schmitt R; Kraaij CJ; Braat SH; Gassner A; Hagemeijer F; Pozenel H; Prager G; Viersma JW; van der Wall EE
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):746-51. PubMed ID: 1723772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral isradipine on left ventricular function at rest and during exercise in patients with stable chronic angina: a double-blind, placebo-controlled crossover study.
    Delonca J; Kipfer P; Righetti A
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):126-33. PubMed ID: 1375679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
    Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
    Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the calcium antagonist, isradipine, and nifedipine on resting and exercise haemodynamics and the neurohumoral system in patients with stable chronic angina.
    Mitrovic V; Rieckmann C; Kornecki P; Burger KJ; Welzel D; Schlepper M
    Eur Heart J; 1990 May; 11(5):454-61. PubMed ID: 2141313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
    Hansson L; Dahlof B
    Am J Cardiol; 1987 Jan; 59(3):137B-140B. PubMed ID: 2949584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the effects of diltiazem and isradipine in patients with chronic stable angina pectoris].
    Meluzín J; Lupínek Z; Novák M; Rotrekl P
    Vnitr Lek; 1989 Nov; 35(11):1062-71. PubMed ID: 2533763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of essential hypertension with PN 200-110 (isradipine).
    Hamilton BP
    Am J Cardiol; 1987 Jan; 59(3):141B-145B. PubMed ID: 2949585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of felodipine in exertional angina pectoris.
    Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
    Am J Cardiol; 1988 Apr; 61(10):691-5. PubMed ID: 3354431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac function improvement 24 hours after isradipine SRO in patients with chronic stable angina: a double-blind randomized study.
    Doat M; Hacot JP; Pavin D; Righetti A
    Acta Cardiol; 1996; 51(2):155-64. PubMed ID: 8742912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
    Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
    Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the calcium antagonist isradipine in angina pectoris.
    Parker JO; Enjalbert M; Bernstein V
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):661-4. PubMed ID: 2978997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of chronic stable angina with isradipine. A cooperative Latin American study].
    Román O; Alcocer L; Espinoza J; Arcos R; Gómez G; Mayorga E; Buzzi A; Tavella N; Romero C; Kuster F
    Rev Esp Cardiol; 1991 Apr; 44(4):233-40. PubMed ID: 1829846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antianginal effect of tiapamil.
    Gasic S
    Cardiology; 1982; 69 Suppl():209-24. PubMed ID: 6758933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isradipine--another calcium-channel blocker for the treatment of hypertension and angina.
    Lopez LM; Santiago TM
    Ann Pharmacother; 1992 Jun; 26(6):789-99. PubMed ID: 1535246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
    Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
    Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.